Nurix Therapeutics, Inc. Quarterly Employee-related Liabilities, Current in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Nurix Therapeutics, Inc. quarterly Employee-related Liabilities, Current history and growth rate from Q4 2019 to Q3 2024.
  • Nurix Therapeutics, Inc. Employee-related Liabilities, Current for the quarter ending August 31, 2024 was $11.7M, a 1.48% increase year-over-year.
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $11.7M +$171K +1.48% Aug 31, 2024 10-Q 2024-10-11
Q2 2024 $9.17M +$104K +1.15% May 31, 2024 10-Q 2024-07-11
Q1 2024 $16.8M +$10.1M +150% Feb 29, 2024 10-Q 2024-04-10
Q4 2023 $15.3M +$2.14M +16.2% Nov 30, 2023 10-Q 2024-10-11
Q3 2023 $11.5M +$1.22M +11.9% Aug 31, 2023 10-Q 2023-10-12
Q2 2023 $9.07M +$1.21M +15.5% May 31, 2023 10-Q 2023-07-13
Q1 2023 $6.71M +$2.71M +67.6% Feb 28, 2023 10-Q 2023-04-13
Q4 2022 $13.2M +$4.31M +48.7% Nov 30, 2022 10-K 2024-02-15
Q3 2022 $10.3M +$4.31M +71.9% Aug 31, 2022 10-Q 2022-10-06
Q2 2022 $7.86M +$2.87M +57.6% May 31, 2022 10-Q 2022-07-07
Q1 2022 $4M -$3.26M -44.9% Feb 28, 2022 10-Q 2022-04-08
Q4 2021 $8.85M +$3.13M +54.7% Nov 30, 2021 10-K 2023-02-09
Q3 2021 $6M +$2.24M +59.5% Aug 31, 2021 10-Q 2021-10-14
Q2 2021 $4.99M May 31, 2021 10-Q 2021-07-13
Q1 2021 $7.27M Feb 28, 2021 10-Q 2021-04-13
Q4 2020 $5.73M +$1.97M +52.6% Nov 30, 2020 10-K 2022-01-28
Q3 2020 $3.76M Aug 31, 2020 10-Q 2020-10-14
Q4 2019 $3.75M Nov 30, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.